Real-World Evidence of Omnipod<sup>®</sup> 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes-Reference-Cited by-同舟云学术

Real-World Evidence of Omnipod^® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes

Published:2024-08-01 Issue:8 Volume:26 Page:514-525
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Forlenza Gregory P.¹^ORCID,DeSalvo Daniel J.²^ORCID,Aleppo Grazia³,Wilmot Emma G.⁴,Berget Cari¹,Huyett Lauren M.⁵,Hadjiyianni Irene⁵,Méndez José J.⁵,Conroy Lindsey R.⁵,Ly Trang T.⁵^ORCID,Sherr Jennifer L.⁶^ORCID

Affiliation:

1. Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

2. Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

3. Division of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

4. Translational Medical Sciences, University of Nottingham, School of Medicine, Royal Derby Hospital, Derby, United Kingdom.

5. Insulet Corporation, Acton, Massachusetts, USA.

6. Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0578

Reference56 articles.

1. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022

2. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

3. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

4. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generating real‐world evidence on diabetes technology using the CareLink Personal data management system;Diabetes, Obesity and Metabolism;2024-09-04

2. Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ;Diabetes Therapy;2024-05-14

3. The role of automated insulin delivery technology in diabetes;Diabetologia;2024-05-13

4. Real‐world data from first UK Omnipod 5 users: A single‐centre observational study;Diabetes, Obesity and Metabolism;2024-05-02

5. MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias: Response to Inaccurate Allegations;Diabetes Technology & Therapeutics;2024-04-25